Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.
Kinetic barriers in the isomerization of substituted ureas: implications for computer-aided drug design.
DNetDB: The human disease network database based on dysfunctional regulation mechanism.
Therapeutic surfactant-stripped frozen micelles.
Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.
A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs.
DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
QUADrATiC: scalable gene expression connectivity mapping for repurposing FDA-approved therapeutics.
Cross-tissue Analysis of Gene and Protein Expression in Normal and Cancer Tissues.
Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets.